{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:59:26Z","timestamp":1788350366462,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104106"],"award-info":[{"award-number":["82104106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2023-I2M-2-006"],"award-info":[{"award-number":["2023-I2M-2-006"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.apsb.2025.08.019","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:56:11Z","timestamp":1756277771000},"page":"574-595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Endogenic transferrin-targeted cell membrane-coated biomimetic lipo-complexes for efficient targeting and enhanced antitumor efficacy in orthotopic glioblastoma"],"prefix":"10.1016","volume":"16","author":[{"given":"Aihua","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuoya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonggao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingji","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.08.019_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2018.04.035","article-title":"A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery","volume":"279","author":"Ruan","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.08.019_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8013575","article-title":"Diagnostic and therapeutic biomarkers in glioblastoma: current status and future perspectives","volume":"2017","author":"Szopa","year":"2017","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.apsb.2025.08.019_bib3","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1039\/C8CS00805A","article-title":"Emerging blood\u2013brain-barrier-crossing nanotechnology for brain cancer theranostics","volume":"48","author":"Tang","year":"2019","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2025.08.019_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41416-020-01136-5","article-title":"Tumour treating fields therapy for glioblastoma: current advances and future directions","volume":"124","author":"Rominiyi","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.apsb.2025.08.019_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.apsb.2025.08.019_bib6","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1021\/accountsmr.2c00147","article-title":"Self-adaptive nanomaterials for rational drug delivery in cancer therapy","volume":"3","author":"Yang","year":"2022","journal-title":"Acc Mater Res"},{"key":"10.1016\/j.apsb.2025.08.019_bib7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2025.08.019_bib8","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nnano.2016.6","article-title":"Drug delivery: unravelling the stealth effect","volume":"11","author":"Butcher","year":"2016","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2025.08.019_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","article-title":"Crossing the blood\u2013brain barrier with nanoparticles","volume":"270","author":"Zhou","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.08.019_bib10","article-title":"Development of polymeric nanoparticles for blood\u2013brain barrier transfer-strategies and challenges","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2025.08.019_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202402445","article-title":"Revolutionizing neurocare: biomimetic nanodelivery via cell membranes","volume":"36","author":"Liao","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.08.019_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41392-021-00631-2","article-title":"Recent progress in targeted delivery vectors based on biomimetic nanoparticles","volume":"6","author":"Chen","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2025.08.019_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/pharmaceutics13010015","article-title":"Focused ultrasound and microbubbles-mediated drug delivery to brain tumor","volume":"13","author":"Wu","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2025.08.019_bib14","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1021\/acs.nanolett.0c04753","article-title":"A biomimetic drug delivery system by integrating grapefruit extracellular vesicles and doxorubicin-loaded heparin-based nanoparticles for glioma therapy","volume":"21","author":"Niu","year":"2021","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2025.08.019_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mattod.2023.07.003","article-title":"Biomimetic multifunctional nanodrugs enable regulating abnormal tumor metabolism and amplifying PDT-induced immunotherapy for synergistically enhanced tumor ablation","volume":"68","author":"Liu","year":"2023","journal-title":"Mater Today"},{"key":"10.1016\/j.apsb.2025.08.019_bib16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nnano.2015.47","article-title":"Mapping protein binding sites on the biomolecular corona of nanoparticles","volume":"10","author":"Kelly","year":"2015","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2025.08.019_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120888","article-title":"The protein corona hampers the transcytosis of transferrin-modified nanoparticles through blood\u2013brain barrier and attenuates their targeting ability to brain tumor","volume":"274","author":"Xiao","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.08.019_bib18","doi-asserted-by":"crossref","first-page":"11773","DOI":"10.1021\/acsnano.7b08008","article-title":"A decade of the protein corona","volume":"11","author":"Ke","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.08.019_bib19","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1038\/s41467-018-06979-4","article-title":"Cloaking nanoparticles with protein corona shield for targeted drug delivery","volume":"9","author":"Oh","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.08.019_bib20","first-page":"1","article-title":"The protein corona from nanomedicine to environmental science","volume":"24","author":"Mahmoudi","year":"2023","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.apsb.2025.08.019_bib21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpharm.2018.10.011","article-title":"The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system","volume":"552","author":"Xiao","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.08.019_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120305","article-title":"Versatile hollow COF nanospheres via manipulating transferrin corona for precise glioma-targeted drug delivery","volume":"260","author":"Huo","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.08.019_bib23","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/polym14040712","article-title":"Angiopep-2-modified nanoparticles for brain-directed delivery of therapeutics: a review","volume":"14","author":"Habib","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.apsb.2025.08.019_bib24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2174\/1389450123666220207143750","article-title":"CPP-based bioactive drug delivery to penetrate the blood\u2013brain barrier: a potential therapy for glioblastoma multiforme","volume":"23","author":"Mehdipour","year":"2022","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.apsb.2025.08.019_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.biomaterials.2014.10.007","article-title":"Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles","volume":"37","author":"Ruan","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.08.019_bib26","article-title":"Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions","volume":"14","author":"Wu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2025.08.019_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.927219","article-title":"Bibliometric analysis of global research on cancer photodynamic therapy: focus on nano-related research","volume":"13","author":"Cheng","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2025.08.019_bib28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/tcr.201600121","article-title":"Photodynamic therapy: past, present and future","volume":"17","author":"Chilakamarthi","year":"2017","journal-title":"Chem Rec"},{"key":"10.1016\/j.apsb.2025.08.019_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7150\/thno.67300","article-title":"Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy","volume":"12","author":"Ji","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.08.019_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12951-021-00903-7","article-title":"Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges","volume":"19","author":"Liu","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2025.08.019_bib31","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.7150\/thno.73566","article-title":"Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor","volume":"12","author":"Wei","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.08.019_bib32","doi-asserted-by":"crossref","first-page":"32763","DOI":"10.1021\/acsami.1c07323","article-title":"Immune\/hypoxic tumor microenvironment regulation-enhanced photodynamic treatment realized by pH-responsive phase transition-targeting nanobubbles","volume":"13","author":"Zhao","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2025.08.019_bib33","doi-asserted-by":"crossref","first-page":"8026","DOI":"10.1021\/acsami.0c21743","article-title":"Metformin liposome-mediated PD-L1 downregulation for amplifying the photodynamic immunotherapy efficacy","volume":"13","author":"Xiong","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2025.08.019_bib34","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acsnano.8b03788","article-title":"Cancer cell membrane camouflaged nanoparticles to realize starvation therapy together with checkpoint blockades for enhancing cancer therapy","volume":"13","author":"Xie","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.08.019_bib35","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.1021\/acsnano.5b03300","article-title":"In vivo biomolecule corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesicles","volume":"9","author":"Hadjidemetriou","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.08.019_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1385-299X(00)00020-9","article-title":"Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood\u2013brain barrier in vitro","volume":"5","author":"Franke","year":"2000","journal-title":"Brain Res Protoc"},{"key":"10.1016\/j.apsb.2025.08.019_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201901513","article-title":"A hypoxia-responsive albumin-based nanosystem for deep tumor penetration and excellent therapeutic efficacy","volume":"31","author":"Yang","year":"2019","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.08.019_bib38","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1039\/D0TB00539H","article-title":"Multi-stimuli responsive polymeric prodrug micelles for combined chemotherapy and photodynamic therapy","volume":"8","author":"Hu","year":"2020","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.apsb.2025.08.019_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.actbio.2020.01.005","article-title":"Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer","volume":"105","author":"Peng","year":"2020","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2025.08.019_bib40","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02242","article-title":"Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis","volume":"3","author":"Wheaton","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.apsb.2025.08.019_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119580","article-title":"Defeating relapsed and refractory malignancies through a nano-enabled mitochondria-mediated respiratory inhibition and damage pathway","volume":"229","author":"Yang","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.08.019_bib42","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1158\/1078-0432.CCR-13-1787","article-title":"Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response","volume":"19","author":"Zannella","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2025.08.019_bib43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jconrel.2018.07.028","article-title":"Tumor-targeting core\u2013shell structured nanoparticles for drug procedural controlled release and cancer sonodynamic combined therapy","volume":"286","author":"Wang","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.08.019_bib44","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.18.7.076019","article-title":"In vivo photoacoustic lifetime imaging of tumor hypoxia in small animals","volume":"18","author":"Shao","year":"2013","journal-title":"J Biomed Opt"},{"key":"10.1016\/j.apsb.2025.08.019_bib45","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1148\/radiol.14140654","article-title":"Photoacoustic imaging of vascular hemodynamics: validation with blood oxygenation level-dependent MR imaging","volume":"275","author":"Rich","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.apsb.2025.08.019_bib46","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2025.08.019_bib47","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/smll.201102354","article-title":"Enhancing surface interactions with colon cancer cells on a transferrin-conjugated 3D nanostructured substrate","volume":"8","author":"Banerjee","year":"2012","journal-title":"Small"},{"key":"10.1016\/j.apsb.2025.08.019_bib48","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12951-024-02463-y","article-title":"Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE\u2013\/\u2013 mice","volume":"22","author":"Qiu","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2025.08.019_bib49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J Lab Autom"},{"key":"10.1016\/j.apsb.2025.08.019_bib50","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jconrel.2015.07.019","article-title":"Cell membrane-camouflaged nanoparticles for drug delivery","volume":"220","author":"Luk","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.08.019_bib51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12951-023-01802-9","article-title":"Near-infrared light triggered in situ release of CO for enhanced therapy of glioblastoma","volume":"21","author":"Ge","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2025.08.019_bib52","article-title":"Fiber optic-mediated type I photodynamic therapy of brain glioblastoma based on an aggregation-induced emission photosensitizer","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.08.019_bib53","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1021\/nl2031663","article-title":"M13 phage-functionalized single-walled carbon nanotubes as nanoprobes for second near-infrared window fluorescence imaging of targeted tumors","volume":"12","author":"Yi","year":"2012","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2025.08.019_bib54","doi-asserted-by":"crossref","first-page":"12086","DOI":"10.1002\/anie.201407420","article-title":"Epitaxial seeded growth of rare-earth nanocrystals with efficient 800 nm near-infrared to 1525 nm short-wavelength infrared downconversion photoluminescence for in vivo bioimaging","volume":"53","author":"Wang","year":"2014","journal-title":"Angew Chem Int Ed Engl"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525005714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525005714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T17:05:16Z","timestamp":1771520716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525005714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2211383525005714"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.08.019","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenic transferrin-targeted cell membrane-coated biomimetic lipo-complexes for efficient targeting and enhanced antitumor efficacy in orthotopic glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}